Announcements Trials
Browse Landscape

Phase

Phase 1 3Phase 2 1

Status

Terminated 1Not yet recruiting 1Completed 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 3

Conditions

Prostatic Neoplasms 3Brain Neoplasms 2Urinary Bladder Neoplasms 1Solid Tumor 1Ovarian Neoplasms 1Oligodendroglioma 1Neoplasms 1Neoplasm Metastasis 1Multiple Myeloma 1Lymphoma, T-Cell, Cutaneous 1Lung Neoplasms 1Head and Neck Neoplasms 1Glioma 1Glioblastoma 1Breast Neoplasms 1Astrocytoma 1Advanced Solid Tumor 1Adenocarcinoma of Lung 1

Interventions

Docetaxel 43enzalutamide 31Prednisone 25Abiraterone Acetate 24Magnetic Resonance Spectroscopy 18abiraterone 15pembrolizumab 14bicalutamide 14Radiotherapy 14Cyclophosphamide 13darolutamide 12Leuprolide 12Goserelin 12apalutamide 10Ipilimumab 10olaparib 9Specimen Handling 9Radiosurgery 9Radiation 9Injections 9Biopsy 9Pluvicto 8Paclitaxel 8Radiotherapy, Intensity-Modulated 7Carboplatin 7sargramostim 6fludarabine 6cabazitaxel 6Sirolimus 6Nivolumab 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1 × Prostatic Neoplasms × BID protein, human × Clear all
NCT07090369 2025-07-29

LumOnate

Peter MacCallum Cancer Centre, Australia

Phase 1 Not yet recruiting
20 enrolled
Genitourinary

Prostatic Neoplasms

NCT04421222 2025-02-28

EPI-7386

ESSA Pharmaceuticals

Phase 1 Terminated
71 enrolled
Genitourinary

Prostatic Neoplasms

NCT00405210 2011-05-23

Pharmacokinetic Study of BAY43-9006 and Taxotere to Treat Patient With Prostatic Cancer

Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Phase 1 Completed
38 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡